Complications | None N = 910 | Any* N = 154 | Any vs. None p-value | Major* N = 47 | Major vs. None p-value | Minor* N = 107 | Minor vs. None p-value |
---|---|---|---|---|---|---|---|
C282Y | Â | Â | Â | Â | Â | Â | Â |
   Normal/Hetero, N (%) | 907 (99%) | 154 (100%) | 0.99 | 47 (100%) | 0.99 | 107 (0%) | 0.99 |
   Homo, N (%) | 3 (<1%) | 0 (0%) |  | 0 (0%) |  | 0 (0%) |  |
H63D | Â | Â | Â | Â | Â | Â | Â |
   Normal/Hetero, N (%) | 888 (98%) | 146 (95%) | 0.065 | 44 (94%) | 0.12 | 102 (95%) | 0.19 |
   Homo, N (%) | 22 (2%) | 8 (5%) |  | 3 (6%) |  | 5 (5%) |  |
C282Y/H63D** | Â | Â | Â | Â | Â | Â | Â |
   Allele dose <2 | 870 (96%) | 141 (92%) | 0.043 | 43 (91%) | 0.27 | 98 (92%) | 0.089 |
   Allele dose 2+ | 40 (4%) | 13 (8%) |  | 4 (9%) |  | 9 (8%) |  |